Mass spectrometry has been growing as the analytical technique of choice to analyze and quantitate oligonucleotide drugs from discovery to QC. Characterization of production related impurities or degradation products is of key importance during the approval process of such biopharmaceutical products. LC-MS/MS provides essentials insights in the identity, amount and sequence of the drug and its impurities.
In this webinar you will:
- Gain a deeper understanding of how to measure oligonucleotide in a robust environment with high isotopic fidelity mass spectrometry
- Discover how OligoQuest™ simplifies the characterization and quantification of oligonucleotide and oligonucleotide degradation products
- Learn about tools to simplify the annotation of oligonucleotide MS2 data
For Research Use Only. Not for use in clinical diagnostic procedures.